
Opinion|Videos|July 31, 2024
Myelofibrosis Overview: US Incidence, Prognosis, and Patient Presentation
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, provides an overview of myelofibrosis, covering its incidence and prevalence in the United States as well as patient presentation and prognosis.
Advertisement
Episodes in this series

Now Playing
Video content above is prompted by the following:
- Please provide a brief overview of the incidence and prevalence of myelofibrosis in the United States.
- Can you explain how the prognosis and patient presentation of myelofibrosis differs from other myeloproliferative neoplasms?
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Researchers discover new pathway to fight liver inflammation
2
Weekly autoinjector Leqembi is available for treatment initiation in Alzheimer’s
3
Employer health care costs projected to rise 9.5% in 2027, report finds
4
Anti-inflammatories instead of antifungals for seborrheic dermatitis
5






















